Lotte Steuten

Appointments and Affiliations

Fred Hutchinson Cancer Research Center
Hutchinson Institute for Cancer Outcomes Research (HICOR)
Associate Faculty Member, Appointed: 2014
University of Washington
Pharmaceutical Outcomes Research and Policy Program (PORPP)
Associate Professor, Appointed: 2014
Professional Headshot of Lotte M. Steuten

Mailing Address

1100 Fairview Ave. N. M3-B232
Seattle, Washington 98109
United States


Phone: (206) 667-6956


PhD (cum laude), Maastricht University (NL), Health Technology Assessment and Chronic Disease Management, 2006
MSc, Maastricht University (NL), Health Services Research and Health Economics, 2001

Research Interests

Dr. Steuten’s research interests include developing and applying health economic and decision-analytic research methods to accelerate patient access to high value new screening, diagnostic and treatment options against cancer and other diseases. Her research expertise is in the fields of health economics and health services research. She specializes in developing and applying quantitative (Bayesian) methods for estimating and comparing the expected health and economic benefits of new approaches and interventions in cancer prevention and treatment, and prioritizing data collection to efficiently build the evidence for such promising new interventions.


International Society for Health Technology Assessment (HTAi)
International Society for PharmacoEconomics Outcomes Research (ISPOR)

Honors and Awards

2013, Career Acceleration Award Female Faculty Network, University of Twente
2010, ISPOR Best Podium Presentation Award
2008, Career Acceleration Award Brunel University
2008, Nominated for Best Paper Award International Journal for Technology Assessment in Health Care in 2006 – 2007
2006, Best PhD thesis award from the National Care and Public Health Research School (NL)
2005 & 2006, 1 of 3 nominees for Dutch Medical Technology Assessment Award
2004, Best Publication Award of the Care And Public Health Research Institute (CAPHRI): Steuten LMG, et al. J Clin Epidemiol 2004;57:881-8

Previous Positions

2013, Co-Founder and Director, Acting CEO, PANAXEA BV, Enschede, The Netherlands, Health Economics and Reimbursement
2012-2014, Director of Education, University of Twente, Health Sciences
2012-2014, Associate Professor, University of Twente, Health Technology and Services Research, Biostatistics
2009-2012, Assistant Professor, University of Twente, Health Technology and Services Research
2008-2010, Founder and Director, Care Innovations Research and Consultancy, Health Sciences
2008-2010, Health Economics Consultant, Group Health Research Institute, MacColl Center
2006-2008, Research Fellow, Brunel University, London (UK), Health Economics Research Group/Multidisciplinary Assessment of Technology Centre in Healthcare
2006-2009, Research Fellow (0.2 FTE), Maastricht University (NL), Care and Public Health Research Institute
2005-2006, Postdoc, Maastricht University, Funded by the "Talent for the Future" Grant
2004, Visiting PhD Student, University of York (UK), Centre for Health Economics
2001-2005, PhD Student, Maastricht University, Economic Evaluation of Disease Management Programmes at the Faculty of Health Sciences



02/08/2016 – 12/31/2016: EMD Serono

Project Title: Merkel Cell Carcinoma Burden of Disease Study in the US

Aim: The objective of this project is to describe the Merkel Cell Carcinoma patient population in the US and characterize the patterns of care and burden of illness associated with this malignancy.

Role: PI

12/04/2015 – 11/30/2019: National Institutes of Health / National Cancer Institute (US)

R01 CA195798 (PI: Hsu)

Project Title: Statistical Methods for Genetic Epidemiologic Studies

Aim: Develop statistical methods for estimating absolute risk using gene and environment data, assessing gene-environment interaction and translating findings into public health and personalized recommendations for interventions.

Role: Co-PI

04/14/2000 – 3/31/2021: National Institutes of Health (NIH)/ National Cancer Institute (NCI)

(PI: Feng/Thornquist/Pepe)

Project Title: The Early Detection Research Network: Data Management and Coordinating Center

Aim: The objective of the Data Management and Coordinating Center (DMCC) are to (i) provide coordination of EDRN in order to enhance communication and collaboration among EDRN investigators and with general scientific communities; (ii) coordinate EDRN validation studies; (iii) disseminate cancer biomarker information to broader scientific communities and the public; and (iv) mange the EDRN Core funds.

Role: Co-I

01/01/2016-12/31/2016: The Hope Foundation

Pending (PI: Steuten)

Project Title: SWOG Committees Support Info structure

This award provides salary support for Dr. Steuten’s contribution to the design and analysis of cost-effectiveness studies, in particularly CEAs alongside clinical trials, for the SWOG CEA project.


2005 – 2006: Postdoc funded by  “Kootstra Talent for the Future”

Fellowship of Maastricht University (NL)

Role: PI

2006: PICASSO Project Grant

Long term cost-effectiveness of targeted stop smoking cessation support for patients with COPD.

Role: PI

08/2007 – 08/2014: Engineering & Physics Science Research Council & DoH (UK)

Renewal Grant for the Multidisciplinary Assessment of Technology Centre in Healthcare (MATCH).

Role: PI

03/2011 – 09/2015: “Alpe d’Huzes” ACARE2MOVE Cancer Charity Grant (NL)

Evaluating the Cost-Benefit and Budget Impact of Cancer Rehabilitation Guidelines.

Role: PI

Dr. Steuten’s effort on this project took place from 03/2011-10/2014.


Centralized procurement of MedTech in Europe.

Role: PI

2012: ZonMw Early MTA Methodology Grant

Aim: To develop methods for early MTH of intensive care technologies.

Role: PI

09/2012 – 09/2015: Center for Translational Molecular Medicine Grant (NL)

PI:  Van Harten

Early Cycle Economic Analyses and Value of Information Analysis of Biomarkers for Screening and Diagnosing Breast Cancer, and for Monitoring Breast Cancer Treatment.

Role: Co-PI

Dr. Steuten’s effort on this project took place from 09/2012-10/2014.

09/2012 – 09/2014: Center for Translational Molecular Medicine grant (NL)

Exploratory health economic analysis of emerging biomarkers for breakthrough cancer treatments.

Role: PI

09/2013 – 09/2017: Netherlands Institute for Healthcare Research, ZonMw Early MTA Grant (NL)

PI: Shultz

Early cycle health economic analysis for new mechanical ventilation technologies

Role: Co-PI

Dr. Steuten’s effort on this project took place from 09/2013-10/2014.

06/2014 – 06/2017: European Joint Research Center Grant,  Europe

Aim: Develop a health economic model to assess the effects, costs and budget impact of all “active and healthy aging” innovations developed under the 2013/14 EU Health Research Program.

Role: PI

Dr. Steuten’s effort on this project took place from 06/2014-10/2014.

Recent Publications

Steuten L, Mantjes G.  2016.  Economic value of procalcitonin guidance.. The Lancet. Infectious diseases. 16(9):1000.
Retèl VP, van der Molen L, Steuten LM, van den Brekel MW, Hilgers FJM.  2016.  A cost-effectiveness analysis of using TheraBite in a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy.. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 273(3):709-18. Abstract
Retèl VP, van den Boer C, Steuten LM, Okła S, Hilgers FJ, van den Brekel MW.  2015.  Cost-effectiveness of heat and moisture exchangers compared to usual care for pulmonary rehabilitation after total laryngectomy in Poland.. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 272(9):2381-8. Abstract
Mewes JC, Steuten L, Jzerman MJ, van Harten W.  2015.  Value Of Implementation Of Physical Exercise For Cancer Survivors.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 18(7):A456.

Coming Soon: New Profiles System!

In preparation for the launch of our new profiles system, we are freezing updates to these profiles. If you have any questions, please email

Researcher Profiles


Related Websites


Scientific Divisions